omega-n-methylarginine has been researched along with Experimental Mammary Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Torre, E; Español, AJ; Fiszman, GL; Sales, ME | 1 |
| Bonaventura, J; DeAngelo, J; Dewhirst, MW; Dodge, RK; Meyer, RE; Ong, ET; Shan, S | 1 |
| Calderón, C; Colsky, A; DiNapoli, MR; Fu, YX; Lopez, DM; Sotomayor, EM | 1 |
| Lala, PK; Orucevic, A | 1 |
| Buckley, BJ; Dewhirst, MW; Hughes, CS; Lindberg, RA; Whorton, AR | 1 |
| Bechberger, J; Billiar, TR; Green, AM; Lala, PK; Orucevic, A; Shapiro, RA | 1 |
| Klostergaard, J; Lopez-Berestein, G; Sivaramakrishnan, MR; Tucker, SD | 1 |
| Chenais, B; Lemaire, G; Lepoivre, M; Tenu, JP; Thelander, L; Yapo, A | 1 |
8 other study(ies) available for omega-n-methylarginine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Role of non-neuronal cholinergic system in breast cancer progression.
Topics: Animals; Arginase; Carbachol; Cell Line, Tumor; Cholinergic Agonists; Cyclooxygenase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neurons; Nitric Oxide Synthase Type I; Nitrobenzenes; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Cholinergic; Sulfonamides | 2007 |
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Female; Mammary Neoplasms, Experimental; Microcirculation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Rats; Rats, Inbred F344; Regional Blood Flow; Venules | 1995 |
Decreased macrophage-mediated cytotoxicity in mammary-tumor-bearing mice is related to alteration of nitric-oxide production and/or release.
Topics: Animals; Arginine; Cytotoxicity, Immunologic; Endotoxins; Hydrogen Peroxide; Immunoglobulin Fab Fragments; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitric Oxide; omega-N-Methylarginine; Receptors, Cell Surface; Tumor Necrosis Factor-alpha | 1995 |
Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Interleukin-12; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pleural Effusion; Pulmonary Edema | 1996 |
Ca(2+)-dependent nitric oxide release in endothelial but not R3230Ac rat mammary adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arginine; Calcium; Calcium-Transporting ATPases; Cell Line; Endothelium, Vascular; Female; Fibroblasts; Humans; Immunoblotting; Isoenzymes; Mammary Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thapsigargin | 1996 |
Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.
Topics: Adenocarcinoma; Animals; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Interferon-gamma; Lipopolysaccharides; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-3; Tumor Cells, Cultured | 1999 |
Independence of the pattern of early cytokine release from autoregulation by nitric oxide.
Topics: Adenocarcinoma; Animals; Arginine; Culture Media; Cytokines; Female; Homeostasis; Interferon-gamma; L Cells; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mammary Neoplasms, Experimental; Mice; Nitric Oxide; Nitrites; omega-N-Methylarginine; Peritoneal Cavity; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Dactinomycin; DNA Replication; Interferon-gamma; Interleukin-1; Kinetics; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Nitrites; omega-N-Methylarginine; Recombinant Proteins; Ribonucleotide Reductases; Thymidine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |